Close
CDMO Safety Testing 2026
Novotech

ArisGlobal Acquires Leading Regulatory Data Solution SPORIFY

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

BeOne Signs $2B Trispecific Antibody Deal with Huahui Health

BeOne Medicines has entered into a high-value agreement with...

Quantum Machine Learning in Pharma Research Growth

The convergence of artificial intelligence and quantum processing is opening new avenues for rapid discovery and innovation within the life sciences. By utilizing advanced mathematical models that operate across multi-dimensional datasets, researchers can now identify complex biological patterns and predict molecular behaviors with a speed that surpasses traditional computational methods. This transformation is accelerating the development of novel therapies and providing deeper insights into disease mechanisms, fundamentally altering the trajectory of pharmaceutical research and development.

Quantum Sensors Enabling Advanced Drug Diagnostics

The landscape of medical diagnostics is being reshaped by the introduction of sensing technologies that operate with atomic-level sensitivity. By providing high-fidelity measurements and real-time data, these tools allow for the detection of subtle biological changes and chemical markers that were previously invisible to conventional equipment. This advancement is enhancing the precision of drug testing and clinical monitoring, leading to earlier disease detection and more effective therapeutic interventions across the global healthcare spectrum.
- Advertisement -

ArisGlobal, a leading provider of life sciences software designed to automate core drug development functions with its end-to-end technology platform LifeSphere®, today announces its acquisition of the SPOR (Substances, Products, Organisations, and Referentials) data governance and integration solution, SPORIFY.

SPORIFY provides consistent and ISO IDMP-compliant SPOR data to feed regulatory activities across the product life cycle, enabling more informed, proactive regulatory decisions to benefit public health and safety. It is the trusted SPOR data harmonization technology solution for five of the world’s top 20 largest pharmaceutical companies and several European regulators.

“ArisGlobal is driven by a mission to innovate and positively impact the life sciences industry through technology, and SPORIFY is a perfect example of now being able to deliver this caliber of data capabilities through our global platform,” shares Mike Gordon, CEO at ArisGlobal. “How we help the industry collect, manage, and ultimately make decisions with data is at the heart of what we do—SPORIFY will bring advanced oversight and power to that process for our customers.”

“SPORIFY is considered an indispensable technology resource for the world’s largest pharmaceutical companies and global health authorities and plays a vital role in facilitating data clean up, enrichment, and harmonization as industry stakeholders align to global data standards,” stated Pat Jenakanandhini, Chief Product Officer at ArisGlobal. “I’m excited to work with innovators who share our vision that integrating life sciences technologies throughout the product lifecycle helps customers improve patient safety and bring therapies to market faster.”

This enhancement builds onto what was already the broadest set of regulatory capabilities available on the market today. Bringing the SPORIFY application into the LifeSphere platform accelerates IDMP-compliant LifeSphere RIMS implementations by proactively establishing data governance processes prior to health authority submissions.

“Creating system interoperability for life sciences and facilitating the transfer of structured data submissions to health authorities are integral to SPORIFY’s mission,” said Gary Wilson, Director, CorrIT Ltd. “Working in partnership with ArisGlobal, we’ll have the opportunity to provide those key capabilities to a much wider market as IDMP and interoperable data standards expand globally.”

As the life sciences industry pushes for harmonization of global data standards and earlier collaboration across the life sciences ecosystem, including health authorities like the European Medicines Agency (EMA) where SPOR implementation is following a phased approach, the combination of ArisGlobal and SPORIFY is a natural fit.

Latest stories

Related stories

BeOne Signs $2B Trispecific Antibody Deal with Huahui Health

BeOne Medicines has entered into a high-value agreement with...

Quantum Machine Learning in Pharma Research Growth

The convergence of artificial intelligence and quantum processing is opening new avenues for rapid discovery and innovation within the life sciences. By utilizing advanced mathematical models that operate across multi-dimensional datasets, researchers can now identify complex biological patterns and predict molecular behaviors with a speed that surpasses traditional computational methods. This transformation is accelerating the development of novel therapies and providing deeper insights into disease mechanisms, fundamentally altering the trajectory of pharmaceutical research and development.

Quantum Sensors Enabling Advanced Drug Diagnostics

The landscape of medical diagnostics is being reshaped by the introduction of sensing technologies that operate with atomic-level sensitivity. By providing high-fidelity measurements and real-time data, these tools allow for the detection of subtle biological changes and chemical markers that were previously invisible to conventional equipment. This advancement is enhancing the precision of drug testing and clinical monitoring, leading to earlier disease detection and more effective therapeutic interventions across the global healthcare spectrum.

Quantum Computing Optimizing Pharma Supply Chains

The global distribution of pharmaceutical products is facing unprecedented challenges that demand a new level of logistical precision and resilience. By utilizing advanced analytical models, companies can now navigate complex international networks with greater efficiency, ensuring that temperature-sensitive medicines and life-saving therapies reach their destinations without delay. This evolution toward a more intelligent and responsive supply chain is critical for maintaining public health and responding effectively to emerging medical needs on a global scale.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »